Skip to main content

Table 1 Main characteristic of the patient cohorts included in the analysis and time points of the dose rate and whole-body activity measurements

From: External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies

  Department 1 Department 2
Mean age 71.4 ± 9.2 years 70.3 ± 8.3 years
Mean activity 6.1 ± 0.5 GBq 6.6 ± 0.9 GBq
Time points t i of the dose rate measurement 4, 24, and 48 h p. i. 2, 24, 48, and 72 h p. i.
Time points t j of the whole-body activity measurement   Before the first bladder voiding and 2, 4, 12, 24, 48, and 72 h p. i.